(NP (NP (NP Modulation/NN) (PP of/IN (NP normal/JJ erythroid/JJ differentiation/NN)) (PP by/IN (NP the/DT (NP-COOD (NP endogenous/JJ thyroid/NN hormone/NN) and/CC (NP retinoic/JJ acid/NN)) receptors/NNS)) :/:) (NP (NP a/DT possible/JJ target/NN) (PP for/IN (NP v-erbA/NN oncogene/NN action/NN)) ./.))
(S (NP-SBJ (NP The/DT v-erbA/NN oncogene/NN) ,/, (NP (NP a/DT mutated/VBN version/NN) (PP of/IN (NP (NP the/DT thyroid/NN hormone/NN receptor/NN alpha/NN) (PRN -LRB-/-LRB- (NP c-erbA\/TR-alpha/NN) -RRB-/-RRB-)))) ,/,) (VP (VP-COOD (VP inhibits/VBZ (NP erythroid/JJ differentiation/NN)) and/CC (VP (ADVP constitutively/RB) represses/VBZ (NP (NP transcription/NN) (PP of/IN (NP certain/JJ erythrocyte/NN genes/NNS))))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (NP (NP a/DT normal/JJ function/NN) (PP of/IN (NP the/DT proto-oncogene/NN c-erbA/NN)) (PP in/IN (NP erythropoiesis/NN)))))) ./.)
(S (ADVP Here/RB) (NP-SBJ we/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ-COOD (NP (NP the/DT endogenous/JJ thyroid/NN hormone/NN receptor/NN alpha/NN) (PRN -LRB-/-LRB- (NP c-erbA\/TR-alpha/NN) -RRB-/-RRB-)) and/CC (NP the/DT (ADJP closely/RB related/JJ) (NP (NP retinoic/JJ acid/NN receptor/NN alpha/NN) (PRN -LRB-/-LRB- (NP RAR-alpha/NN) -RRB-/-RRB-)))) (VP play/VBP (NP a/DT role/NN) (PP in/IN (NP (NP the/DT regulation/NN) (PP of/IN (NP normal/JJ erythroid/JJ differentiation/NN)))))))) ./.)
(S (NP-SBJ (NP Retinoic/JJ acid/NN) (PRN -LRB-/-LRB- (NP RA/NN) -RRB-/-RRB-)) (ADVP distinctly/RB) (VP modulated/VBD (NP (NP the/DT erythroid/JJ differentiation/NN program/NN) (PP of/IN (NP (NP-COOD (NP normal/JJ erythroid/JJ progenitors/NNS) and/CC (NP erythroblasts/NNS)) (VP (ADVP reversibly/RB) transformed/VBN (NP */-NONE-) (PP by/IN (NP-LGS a/DT conditional/JJ tyrosine/NN kinase/NN oncogene/NN))))))) ./.)
(S (SBAR-TMP (WHADVP-70 When/WRB) (S (NP-SBJ-71 *-105/-NONE-) (VP added/VBN (NP *-71/-NONE-) (ADVP pulsewise/RB) (PP to/TO (NP immature/JJ cells/NNS)) (ADVP *T*-70/-NONE-)))) ,/, (NP-SBJ-72 differentiation/NN) (VP was/VBD (VP accelerated/VBN (NP-105 *-72/-NONE-) (SBAR while/IN (S (NP-SBJ (ADJP more/RBR mature/JJ) cells/NNS) (VP underwent/VBD (NP premature/JJ cell/NN death/NN)))))) ./.)
(S (NP-SBJ (NP (NP Thyroid/NN hormone/NN) (PRN -LRB-/-LRB- (NP T3/NN) -RRB-/-RRB-)) (ADVP alone/RB)) (VP caused/VBD (NP (ADJP-COOD (ADJP similar/JJ) but/CC (ADJP weaker/JJR)) effects/NNS)) ./.)
(S (ADVP Interestingly/RB) ,/, (NP-SBJ T3/NN) (ADVP strongly/RB) (VP enhanced/VBD (NP (NP the/DT action/NN) (PP of/IN (NP RA/NN))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (NP (NP cooperative/JJ action/NN) (PP of/IN (NP the/DT two/CD receptors/NNS)) (PP in/IN (S (NP-SBJ */-NONE-) (VP modulating/VBG (NP erythroid/JJ differentiation/NN)))))))) ./.)
(S (NP-SBJ (NP Expression/NN) (PP of/IN (NP the/DT human/JJ RAR-alpha/NN)) (PP in/IN (NP receptor-negative/JJ erythroblasts/NNS))) (VP conferred/VBD (NP RA-induced/JJ regulation/NN) (PP of/IN (NP differentiation/NN)) (PP to/TO (NP the/DT (ADJP otherwise/RB unresponsive/JJ) cells/NNS)) ,/, thus/RB (S (NP-SBJ */-NONE-) (VP showing/VBG (SBAR that/IN (S (NP-SBJ the/DT RAR-alpha/NN) (VP is/VBZ (ADJP-PRD essential/JJ (PP for/IN (NP the/DT RA/NN effect/NN))))))))) ./.)
(S (ADVP Likewise/RB) ,/, (NP-SBJ (NP enhanced/VBN expression/NN) (PP of/IN (NP exogenous/JJ c-erbA\/TR-alpha/NN)) (PP in/IN (NP erythroblasts/NNS))) (VP rendered/VBD (S (NP-SBJ them/PRP) (ADJP-PRD susceptible/JJ (PP to/TO (NP (NP modulation/NN) (PP of/IN (NP differentiation/NN)) (PP by/IN (NP T3/NN)))))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (NP (NP a/DT similar/JJ function/NN) (PP of/IN (NP both/DT receptors/NNS)))))) ./.)
